-
Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.
Diabetes therapy : research, treatment and education of diabetes and related disorders 20121201
-
Intestinal alpha-glucosidase inhibitors: abdominal gas cysts.
Prescrire international 20120901
-
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation.
Diabetes & vascular disease research 20120701
-
Differential effects of α-glucosidase inhibitors on postprandial plasma glucose and lipid profile in patients with type 2 diabetes under control with insulin lispro mix 50/50.
Diabetes technology & therapeutics 20120701
-
In vitro cytotoxic, antioxidative and alpha-glucosidase inhibitory potential of a herbal mixture comprised of Allium sativum and Lagerstroemia speciosa.
European review for medical and pharmacological sciences 20120701
-
Nutrient detection by incretin hormone secreting cells.
Physiology & behavior 20120606
-
Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
Acta diabetologica 20120601
-
Effect of miglitol as an add-on to bolus insulin on postprandial glycemic excursions in type 2 diabetes patients assessed by continuous glucose monitoring.
Diabetes technology & therapeutics 20120501
-
Anorexigenic effects of miglitol in concert with the alterations of gut hormone secretion and gastric emptying in healthy subjects.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20120401
-
Newer insights into the drug delivery approaches of α-glucosidase inhibitors.
Expert opinion on drug delivery 20120401
-
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.
PLoS medicine 20120401
-
Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients.
Diabetes, obesity & metabolism 20120301
-
Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease.
The American journal of cardiology 20120101
-
Preventive pharmacotherapy in type 2 diabetes mellitus.
Indian journal of endocrinology and metabolism 20120101
-
Effect of the α-glucosidase inhibitor miglitol on the glucose profile in Japanese type 2 diabetic patients receiving multiple daily insulin injections.
Endocrine journal 20120101
-
Performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations.
PloS one 20120101
-
Efficacy of various antidiabetic agents as add-on treatments to metformin in type 2 diabetes mellitus: systematic review and meta-analysis.
ISRN endocrinology 20120101
-
The management of type 2 diabetic patients with hypoglycaemic agents.
ISRN endocrinology 20120101
-
Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan.
Diabetes, metabolic syndrome and obesity : targets and therapy 20120101
-
Polymer-based delivery of glucagon-like Peptide-1 for the treatment of diabetes.
ISRN endocrinology 20120101
-
Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol.
Internal medicine (Tokyo, Japan) 20120101
-
Miglitol, an anti-diabetic drug, inhibits oxidative stress-induced apoptosis and mitochondrial ROS over-production in endothelial cells by enhancement of AMP-activated protein kinase.
Journal of pharmacological sciences 20120101
-
Study of the inhibition of two human maltase-glucoamylases catalytic domains by different α-glucosidase inhibitors.
Carbohydrate research 20111213
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes.
Metabolism: clinical and experimental 20111101
-
Both stimulation of GLP-1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia-reperfusion injury in rabbits.
British journal of pharmacology 20110901
-
Iminosugars as therapeutic agents: recent advances and promising trends.
Future medicinal chemistry 20110901
-
Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase.
Bioorganic & medicinal chemistry 20110701
-
Targeting enteral endocrinal L-cells with dietary carbohydrates, by increasing the availability of miglitol in the intestinal lumen, leads to multi-fold enhancement of plasma glucagon-like peptide-1 levels in non-diabetic canines.
Drug development and industrial pharmacy 20110501
-
Primary language, income and the intensification of anti-glycemic medications in managed care: the (TRIAD) study.
Journal of general internal medicine 20110501
-
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.
Diabetes care 20110401
-
Cohort study of pioglitazone and cancer incidence in patients with diabetes.
Diabetes care 20110401
-
Ultra-performance liquid chromatography electrospray ionization-tandem mass spectrometry method for the estimation of miglitol in human plasma using metformin as the internal standard.
Drug testing and analysis 20110401
-
Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus.
Nutrition research and practice 20110401
-
Efficacy of combined use of miglitol in Type 2 diabetes patients receiving insulin therapy-placebo-controlled double-blind comparative study.
Acta diabetologica 20110301
-
Evaluation of the efficacy and tolerability of miglitol in Chinese patients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas.
Acta diabetologica 20110301
-
Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.
Intensive care medicine 20110301
-
Comparing the efficacy of α-glucosidase inhibitors in suppressing postprandial hyperglycemia using continuous glucose monitoring: a pilot study-the MAJOR study.
Diabetes technology & therapeutics 20110301
-
Glycosylation failure extends to glycoproteins in gestational diabetes mellitus: evidence from reduced α2-6 sialylation and impaired immunomodulatory activities of pregnancy-related glycodelin-A.
Diabetes 20110301
-
Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol.
Clinical and experimental nephrology 20110201
-
The role of alpha-glucosidase in germinating barley grains.
Plant physiology 20110201
-
The synthesis and biological evaluation of 1-C-alkyl-L-arabinoiminofuranoses, a novel class of α-glucosidase inhibitors.
Bioorganic & medicinal chemistry letters 20110115
-
Antidiabetic Indian plants: a good source of potent amylase inhibitors.
Evidence-based complementary and alternative medicine : eCAM 20110101
-
Advances in the treatment of type 2 diabetes mellitus.
American journal of therapeutics 20110101
-
Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro.
Evidence-based complementary and alternative medicine : eCAM 20110101
-
Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants.
BMC complementary and alternative medicine 20110101
-
A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control.
Nutrition journal 20110101
-
Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case series.
Journal of medical case reports 20110101
-
In vitro and in vivo anti-hyperglycemic effects of Omija (Schizandra chinensis) fruit.
International journal of molecular sciences 20110101
-
Cinnamon extract inhibits α-glucosidase activity and dampens postprandial glucose excursion in diabetic rats.
Nutrition & metabolism 20110101
-
Antihyperglycemic effect of the alcoholic seed extract of Swietenia macrophylla on streptozotocin-diabetic rats.
Pharmacognosy research 20110101
-
Effects of onion (Allium cepa L.) extract administration on intestinal α-glucosidases activities and spikes in postprandial blood glucose levels in SD rats model.
International journal of molecular sciences 20110101
-
Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus.
International journal of general medicine 20110101
-
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.
Endocrine journal 20110101
-
Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endothelial function--a crossover trial (AGENT).
Cardiovascular diabetology 20110101
-
A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients.
Health and quality of life outcomes 20110101
-
Medicinal chemistry of novel anti-diabetic drugs.
The open medicinal chemistry journal 20110101
-
Synthesis and α-glucosidase inhibitory mechanisms of bis(2,3-dibromo-4,5-dihydroxybenzyl) ether, a potential marine bromophenol α-glucosidase inhibitor.
Marine drugs 20110101
-
Management of diabetes across the course of disease: minimizing obesity-associated complications.
Diabetes, metabolic syndrome and obesity : targets and therapy 20110101
-
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
Cardiovascular diabetology 20110101
-
The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 20101201
-
Hypoglycemic effects of Welsh onion in an animal model of diabetes mellitus.
Nutrition research and practice 20101201
-
Probing the active-site requirements of human intestinal N-terminal maltase-glucoamylase: Synthesis and enzyme inhibitory activities of a six-membered ring nitrogen analogue of kotalanol and its de-O-sulfonated derivative.
Bioorganic & medicinal chemistry 20101115
-
Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis.
Diabetes care 20101101
-
Changes in α-glucosidase activities along the jejunal-ileal axis of normal rats by the α-glucosidase inhibitor miglitol.
Metabolism: clinical and experimental 20101001
-
Amplification of the inhibitory activity and reversal of the selectivity of miglitol by C(2')-monofluorination.
Archiv der Pharmazie 20101001
-
The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis.
Diabetes care 20100801
-
Recommendations for management of diabetes during Ramadan: update 2010.
Diabetes care 20100801
-
Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic patients with coronary heart disease (J-MACH) -.
Circulation journal : official journal of the Japanese Circulation Society 20100701
-
Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis.
International journal of clinical practice 20100601
-
Drug utilization of oral hypoglycemic agents in a university teaching hospital in India.
Journal of clinical pharmacy and therapeutics 20100601
-
Computational identification of uncharacterized cruzain binding sites.
PLoS neglected tropical diseases 20100501
-
A case of insulinoma following total gastrectomy--effects of an alpha-glucosidase inhibitor on suppressing GIP and GLP-1 elevations.
Diabetes research and clinical practice 20100401
-
Disordered eating behavior in individuals with diabetes: importance of context, evaluation, and classification.
Diabetes care 20100301
-
Glucose supply and insulin demand dynamics of antidiabetic agents.
Journal of diabetes science and technology 20100301
-
Development and validation of HPLC-UV-MS method for the control of four anti-diabetic drugs in suspected counterfeit products.
Yao xue xue bao = Acta pharmaceutica Sinica 20100301
-
Dual-action lipophilic iminosugar improves glycemic control in obese rodents by reduction of visceral glycosphingolipids and buffering of carbohydrate assimilation.
Journal of medicinal chemistry 20100128
-
New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata.
Biochemistry 20100126
-
Glycosidase inhibition: assessing mimicry of the transition state.
Organic & biomolecular chemistry 20100121
-
Aspects of insulin treatment.
Diabetes care 20100101
-
Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk.
Vascular health and risk management 20100101
-
Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men.
Endocrine journal 20100101
-
Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men.
Endocrine journal 20100101
-
Comparison of adverse gastrointestinal effects of acarbose and miglitol in healthy men: a crossover study.
Internal medicine (Tokyo, Japan) 20100101
-
Pneumatosis cystoides intestinalis induced by the α-glucosidase inhibitor miglitol.
Internal medicine (Tokyo, Japan) 20100101
-
Antioxidant rich grape pomace extract suppresses postprandial hyperglycemia in diabetic mice by specifically inhibiting alpha-glucosidase.
Nutrition & metabolism 20100101
-
Reduced expression of β2 integrin genes in rat peripheral leukocytes by inhibiting postprandial hyperglycemia.
Bioscience, biotechnology, and biochemistry 20100101
-
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents.
Diabetes, metabolic syndrome and obesity : targets and therapy 20100101
-
Stability-Indicating RP-HPLC Method for Estimation of Miglitol in Bulk and Tablets.
Indian journal of pharmaceutical sciences 20100101
-
The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats.
European journal of pharmacology 20091210
-
Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
International journal of pharmaceutics 20091001
-
Amplification of the inhibitory activity of miglitol by monofluorination.
Bioorganic & medicinal chemistry letters 20091001
-
The alpha-glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin-1beta and tumour necrosis factor-alpha gene expression in rat peripheral leucocytes induced by intermittent sucrose loading.
The British journal of nutrition 20090701
-
The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes.
Nutrition (Burbank, Los Angeles County, Calif.) 20090601
-
Effect of miglitol, an alpha-glucosidase inhibitor, on atherogenic outcomes in balloon-injured diabetic rats.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20090301
-
Diabetes treatment.
Diabetes care 20090301
-
Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese Type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 20090201
-
Rapid quantification of miglustat in human plasma and cerebrospinal fluid by liquid chromatography coupled with tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090115
-
Effect of insulin-unstimulated diabetic therapy with miglitol on serum cystatin C level and its clinical significance.
Diabetes research and clinical practice 20090101
-
Postprandial hyperglycemia as an etiological factor in vascular failure.
Cardiovascular diabetology 20090101
-
Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes.
Nutrition & metabolism 20090101
-
Hypoglycemic herbs and their action mechanisms.
Chinese medicine 20090101
-
Suppressive response of confections containing the extractive from leaves of Morus Alba on postprandial blood glucose and insulin in healthy human subjects.
Nutrition & metabolism 20090101
-
A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease.
Cardiovascular diabetology 20090101
-
Design, statistical analysis and sample size calculation of a phase IIb/III study of linagliptin versus voglibose and placebo.
Trials 20090101
-
Drugs associated with more suicidal ideations are also associated with more suicide attempts.
PloS one 20090101
-
Pneumatosis cystoides intestinalis of the ascending colon related to acarbose treatment: a case report.
Journal of medical case reports 20090101
-
Acute metabolic responses to a high-carbohydrate meal in outpatients with type 2 diabetes treated with a low-carbohydrate diet: a crossover meal tolerance study.
Nutrition & metabolism 20090101
-
Postprandial hypoglycemic effect of mulberry leaf in Goto-Kakizaki rats and counterpart control Wistar rats.
Nutrition research and practice 20090101
-
Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy.
Diabetes, metabolic syndrome and obesity : targets and therapy 20090101
-
Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes.
Vascular health and risk management 20081201
-
Synthesis of iminoalditol analogues of galactofuranosides and their activities against glycosidases.
Carbohydrate research 20081124
-
Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
Metabolism: clinical and experimental 20080901
-
Comparison of pre- vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients.
Diabetes, obesity & metabolism 20080901
-
In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures.
Bioorganic & medicinal chemistry 20080801
-
Alpha-glucosidase-like activity detected in a siboglinid polychaete, Oligobrachia mashikoi.
Zoological science 20080401
-
Effect of butanol fraction from Cassia tora L. seeds on glycemic control and insulin secretion in diabetic rats.
Nutrition research and practice 20080101
-
Divided-dose administration of miglitol just before and 15 minutes after the start of a meal smoothes postprandial plasma glucose excursions and serum insulin responses in healthy men.
Endocrine journal 20071201
-
[In-vitro study of the drug interactions between Miglitol, an alpha-glucosidase inhibitor, and adsorbents].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20071201
-
Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 20071101
-
[Adverse effects of alpha-glucosidase inhibitors].
Nihon rinsho. Japanese journal of clinical medicine 20071028
-
Administration of miglitol until 30 min after the start of a meal is effective in type 2 diabetic patients.
Diabetes research and clinical practice 20071001
-
Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats.
The British journal of nutrition 20071001
-
Optimizing combination treatment in the management of type 2 diabetes.
Vascular health and risk management 20071001
-
Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice.
Biochemical and biophysical research communications 20070706
-
Evaluation of the efficacy, safety and tolerability of miglitol in adult Indian patients with uncomplicated type 2 diabetes mellitus.
Journal of the Indian Medical Association 20070601
-
Indian herbs and herbal drugs used for the treatment of diabetes.
Journal of clinical biochemistry and nutrition 20070501
-
Imino sugars are potent agonists of the human glucose sensor SGLT3.
Molecular pharmacology 20070201
-
Determination of miglitol in human plasma by liquid chromatography/tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM 20070101
-
[Iminosugars: current and future therapeutic applications].
Annales pharmaceutiques francaises 20070101
-
Thioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetes.
International journal of medical sciences 20070101
-
The genus Gluconobacter oxydans: comprehensive overview of biochemistry and biotechnological applications.
Critical reviews in biotechnology 20070101
-
Hypoglycemic and hypolipidemic effects of Saururus chinensis Baill in streptozotocin-induced diabetic rats.
Nutrition research and practice 20070101
-
Inhibition of recombinant human maltase glucoamylase by salacinol and derivatives.
The FEBS journal 20060601
-
Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia.
International journal of clinical practice 20060301
-
[Pharmacokinetic, pharmacological, and clinical profile of miglitol (SEIBULE), a novel alpha-glucosidase inhibitor].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20060301
-
Liquid chromatographic tandem mass spectrometry method for the quantification of miglitol in human plasma.
Arzneimittel-Forschung 20060101
-
The anti-diabetic drug miglitol is protective against anginal ischaemia through a mechanism independent of regional myocardial blood flow in the dog.
Clinical and experimental pharmacology & physiology 20051001
-
Prediction of genotoxicity of chemical compounds by statistical learning methods.
Chemical research in toxicology 20050601
-
Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
The Cochrane database of systematic reviews 20050418
-
Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.
Diabetes care 20050101
-
Cardiovascular risk factors associated with insulin resistance: effects of oral antidiabetic agents.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101
-
C-glycosides and aza-C-glycosides as potential glycosidase and glycosyltransferase inhibitors.
Current topics in medicinal chemistry 20050101
-
Synthesis and glycosidase inhibitory activity of new hexa-substituted C8-glycomimetics.
Beilstein journal of organic chemistry 20050101
-
Antidiabetic drug miglitol inhibits myocardial apoptosis involving decreased hydroxyl radical production and Bax expression in an ischaemia/reperfusion rabbit heart.
British journal of pharmacology 20040701
-
The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.
Diabetes, obesity & metabolism 20040301
-
[Usefulness of miglitol in patients with diabetes mellitus type 2 and insufficient control of the blood glucose].
Revista clinica espanola 20040101
-
[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
MMW Fortschritte der Medizin 20031218
-
[Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes].
MMW Fortschritte der Medizin 20030227
-
Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?
Drugs 20030101
-
Biochemistry and biotechnological applications of Gluconobacter strains.
Applied microbiology and biotechnology 20021101
-
Therapeutic options for the management of type 2 diabetes mellitus.
The American journal of managed care 20021101
-
HbA(1c) and glycemic profile, basal- and post-treatment with Miglitol, in an area with a Mediterranean diet.
Diabetes care 20021001
-
The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
Diabetes, obesity & metabolism 20020901
-
Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study.
Diabetes, nutrition & metabolism 20020601
-
[Postprandial hyperglycemia. II. Pharmacological approaches].
Revue medicale de Liege 20020401
-
Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications.
Nutrition, metabolism, and cardiovascular diseases : NMCD 20020401
-
New sugar-mimic alkaloids from the pods of Angylocalyx pynaertii.
Journal of natural products 20020201
-
Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.
Diabetes care 20020101
-
[Reducing postprandial glucose levels. Glucosidase antagonists].
Pharmazie in unserer Zeit 20020101
-
Postprandial hyperglycemia in patients with type 2 diabetes mellitus.
Treatments in endocrinology 20020101
-
Critical Importance of alpha-glucosidase contained in rice kernel for alcohol fermentation of rice polish.
Journal of bioscience and bioengineering 20020101
-
Miglitol combined with metformin improves glycaemic control in type 2 diabetes.
Diabetes, obesity & metabolism 20011001
-
Pathophysiologic mechanisms of postprandial hyperglycemia.
The American journal of cardiology 20010920
-
Combination of miglitol, an anti-diabetic drug, and nicorandil markedly reduces myocardial infarct size through opening the mitochondrial K(ATP) channels in rabbits.
British journal of pharmacology 20010801
-
[The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office].
Fortschritte der Medizin. Originalien 20010719
-
A new era in type 2 diabetes mellitus treatment?
The American journal of medicine 20010701
-
The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes.
Diabetes care 20010601
-
[Current and future aspects of oral antidiabetic agents in type 2 diabetes].
Vnitrni lekarstvi 20010501
-
[Alpha-glucosidase inhibitor in type 2 diabetic patients. Metabolism and body weight are favorably modified].
MMW Fortschritte der Medizin 20010426
-
Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics.
Diabetes research and clinical practice 20010301
-
Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20010101
